PORTOLA PHARMACEUTICALS INC's ticker is and the CUSIP is 737010958. A total of 4 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $649,000 | +256.6% | 361 | +41.0% | 0.00% | – |
| Q1 2020 | $182,000 | -45.8% | 256 | +81.6% | 0.00% | -100.0% |
| Q4 2019 | $336,000 | -53.4% | 141 | -47.6% | 0.00% | -50.0% |
| Q3 2019 | $721,000 | +34.3% | 269 | +35.9% | 0.00% | +100.0% |
| Q2 2019 | $537,000 | -26.9% | 198 | -6.6% | 0.00% | -50.0% |
| Q1 2019 | $735,000 | +78.0% | 212 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $413,000 | -38.6% | 212 | -16.2% | 0.00% | -50.0% |
| Q3 2018 | $673,000 | -27.2% | 253 | +3.3% | 0.00% | -50.0% |
| Q2 2018 | $925,000 | +297.0% | 245 | -27.7% | 0.00% | -60.0% |
| Q1 2018 | $233,000 | +35.5% | 339 | +9.4% | 0.01% | +42.9% |
| Q4 2017 | $172,000 | +93.3% | 310 | +49.8% | 0.01% | +75.0% |
| Q3 2017 | $89,000 | +67.9% | 207 | -42.8% | 0.00% | +100.0% |
| Q2 2017 | $53,000 | +278.6% | 362 | +432.4% | 0.00% | +100.0% |
| Q1 2017 | $14,000 | -87.0% | 68 | -92.0% | 0.00% | -83.3% |
| Q4 2016 | $108,000 | -43.5% | 845 | +176.1% | 0.01% | -53.8% |
| Q3 2016 | $191,000 | – | 306 | +30500.0% | 0.01% | – |
| Q2 2016 | $0 | -100.0% | 1 | -99.5% | 0.00% | -100.0% |
| Q1 2016 | $330,000 | +59.4% | 200 | -29.6% | 0.03% | +62.5% |
| Q4 2015 | $207,000 | +71.1% | 284 | +178.4% | 0.02% | +77.8% |
| Q3 2015 | $121,000 | +255.9% | 102 | +161.5% | 0.01% | +200.0% |
| Q2 2015 | $34,000 | +41.7% | 39 | +11.4% | 0.00% | 0.0% |
| Q1 2015 | $24,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 50,100 | $1,334,000 | 0.01% |
| SIMPLEX TRADING, LLC | 253 | $673,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 82,100 | $2,186,000 | 0.00% |